Poxel Announces Symposium Presentation for Imeglimin at 55th Annual Meeting of the European Association for the Study of Diabetes; Detailed Imeglimin Phase 3 TIMES 1 results to be presented at EASD; session chaired by Ralph DeFronzo, M.D., leading academi

Press/Media: Press / Media

PeriodSep 9 2019

Media coverage

2

Media coverage

  • TitlePoxel Announces Symposium Presentation for Imeglimin at 55th Annual Meeting of the European Association for the Study of Diabetes; Detailed Imeglimin Phase 3 TIMES 1 results to be presented at EASD; session chaired by Ralph DeFronzo, M.D., leading academi
    Media name/outletBusiness Wire
    CountryUnited States
    Date9/9/19
    PersonsRalph A Defronzo
  • TitlePoxel Announces Symposium Presentation for Imeglimin at 55th Annual Meeting of the European Association for the Study of Diabetes; Detailed Imeglimin Phase 3 TIMES 1 results to be presented at EASD; session chaired by Ralph DeFronzo, M.D., leading academi
    Media name/outletBusiness Wire
    CountryUnited States
    Date9/9/19
    PersonsRalph A Defronzo